NEWSpublisher 2007 :: AngloChinese Investments
SEARCH COMPANY
name:
trunover in millions USD:
from:    to: 
R & D turnover in millions USD:
from:     to: 
NET profit:
from:    to: 
employees:
from:    to: 
COMPANIES
APPROVALS
ACTIVITIES ENGAGED IN
R & D
CLINICAL TRIALS
NON CLINICAL & PRECLINICAL
CHEMISTRY-CONTRACT MANUFACTURE
TEST
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY DETAILS » Merck & Co back to previous page show list

Merck & Co

»
address: stawwe
contact:

trunover in millions USD: 22011
R & D turnover in millions USD: 3847
NET profit: 4630
year of financial results: 2006
employees: 0

active in China: NO
partner in China: Merck China
40F, United Plaza
1468 Nanjing Xi Road
200040 Shanghai

SFDA approved: NO

Approvals:
GLP: NO
GMP: NO
AAALAC: NO
SEPA: NO

Activities engaged in:
Manufacture: NO
Active Pharmaceutical: NO
R&D: NO
Ingredients: NO
Western Generics: NO
TCM: NO

R & D:
Discovery: NO
Work Up (pilot to production): NO
Analysis: NO
Quality Control: NO
Stability: NO
Batch Release: NO

Clinical trials:
Run/Manage: NO
Data management: NO
Support Labs: NO

Non clinical & preclinical:
Animal Testing: GLP: NO
New materials Safety Assessment: NO
Pharmaceuticals: NO
Agrochemicals: NO
Industrial & Other Chemicals: NO
Non GLP - Discovery ADME: NO

Chemistry-contract manufacture:
Generics: NO
API: NO
Licensed Drugs: NO

test:
R&D: NO
 

Merck & Co is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service Our mission is to provide people with superior products and services by developing innovations and solutions that improve the quality of life.

The focus of research at Merck is on innovation in all areas of drug research and development, working on programs to satisfy unmet medical needs.

With approximately 61,500 employees, Merck conducts research at 10 major research centers worldwide, manufactures products in 31 facilities, and operates in more than 140 countries.

Our strategy for growth is based on breakthrough research – both internally and externally through partnerships – and demonstrating the value of our medicines to patients, payers, and providers. Worldwide sales in 2005 were $22 billion. We continue to invest heavily in research and development, with $3.8 billion in 2005 R&D spending.

Merck’s product line includes a broad portfolio of highly innovative prescription products in important therapeutic areas. These include medicines to treat high blood pressure, elevated cholesterol levels, osteoporosis, asthma, benign prostatic hyperplasia, arthritis, migraine, glaucoma, emesis, infectious diseases (antibacterial, antifungal, and antiviral agents), and vaccines to prevent childhood diseases and hepatitis A and B.

Merck & Co.,Inc in China

Merck Sharp & Dohme (China) Co.Ltd in 1992.
Hangzhou Merck Sharp & Dohme Pharmaceuticals Group Co. Ltd. in 1994.The area of the factary is 12,000 sq.m

Hangzhou MSD Pharmaceutical Co. Ltd. Room 517-521,Zhejin Plaza, No.78, Feng Qi Road, Hangzhou 310003, China
ChinaPost Code : 310003
Tel: +86 0571 8527-1999
Fax: +86 0571 8527-1810

Hangzhou MSD Pharmaceutical Co. Ltd. - (PLANT)
864 Moganshan Rd., Hangzhou 310011, China
ChinaPost Code : 310011
Tel : +86 0571 8817-0994
Fax : +86 0571 8817-0672

 

 


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.